— Why it moved
Why NUWE Stock More Than Tripled Today — July 30, 2026
Three pieces of good news in four days, landing on a float of roughly 60,000 shares after a 1-for-35 reverse split.
What moved NUWE stock
Nuwellis makes the Aquadex system, which pulls excess fluid off patients with heart failure — increasingly in paediatric and critical care settings. Three things landed in four days: preliminary Q2 revenue guided up 14% year over year (first-half up 20%) on 27 July, the first Aquadex SmartFlow installations in Wisconsin children's hospitals on 28 July, and a new US patent on its Dual Lumen Catheter. None of these is individually large. Together they gave the tape a reason.
The mechanics
The reason a 14% revenue guide produced a triple is the share count. Nuwellis recently completed a 1-for-35 reverse split, which left a float of roughly 60,000 shares. That is not a typo, and it is the entire story of the chart: 117 million shares traded on Thursday against a float you could count in an afternoon. At that ratio, ordinary buying is a squeeze.
NUWE by the numbers
The alert window
Stock Pulse alerted at 7:00 AM in the premarket at $3.99, and this is the rare one where holding was comfortable. The worst it traded between the alert and the peak was $3.90, 2% under. It was up 31% by 9:00, opened at $5.14, and topped at $6.40 at 9:42 — two hours and forty-two minutes after the ping. Of the 731 minutes from alert to the end of the session, 552 closed above the alert price.
How NUWE's move ended
$4.48 at the bell, 12% above the alert, with the regular-session low at $3.70. The risks are the ones that come stapled to any float this thin: an offering inside the last 60 days, a 52-week high of $908 that exists only because of repeated reverse splits, and a company still burning cash on a device business measured in single-digit millions.
The tell: a 60,000-share float turns modest news into a squeeze, and the same arithmetic works in reverse on the way out. The float is the trade, not the patent.